Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409045 · ClinicalTrials.gov registry record
Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism
A clinical trial of Obstructive Sleep Apnea and Pulmonary Embolism, sponsored by Atlantic Health System.
- Completed
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT00409045: Completed study of Obstructive Sleep Apnea and Pulmonary Embolism, sponsored by Atlantic Health System.
NCT00409045 is a study of Obstructive Sleep Apnea and Pulmonary Embolism that has completed, run by Atlantic Health System. The registered enrollment target is 300 participants, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00409045, a study of Obstructive Sleep Apnea and Pulmonary Embolism, has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
we evaluate the presence of OSA in patients that have a computed tomography (CT) of the chest to rule out pulmonary embolism (PE) to determine if OSA constitutes an independent risk factor for PE.
Conditions Studied
Study Locations (1)
New Jersey
- Morristown Memorial Hospital - Morristown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-09 |
What the finished NCT00409045 record still lists
NCT00409045 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (36% higher).
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT00409045 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00409045 about?
NCT00409045 is a clinical study titled "Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism". we evaluate the presence of OSA in patients that have a computed tomography (CT) of the chest to rule out pulmonary embolism (PE) to determine if OSA constitutes an independent risk factor for PE.
What is the current status of trial NCT00409045?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2005-11. Estimated completion is 2007-09.
What conditions does trial NCT00409045 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Pulmonary Embolism.
Who is sponsoring clinical trial NCT00409045?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00409045 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00409045's enrollment target sits among peer trials
300 24th of 155 higher than 132 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia